AR069511A1 - Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas - Google Patents

Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas

Info

Publication number
AR069511A1
AR069511A1 ARP080105224A ARP080105224A AR069511A1 AR 069511 A1 AR069511 A1 AR 069511A1 AR P080105224 A ARP080105224 A AR P080105224A AR P080105224 A ARP080105224 A AR P080105224A AR 069511 A1 AR069511 A1 AR 069511A1
Authority
AR
Argentina
Prior art keywords
recombination
sequence
attp
attr
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ARP080105224A
Other languages
English (en)
Inventor
Barbara Enenkel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR069511A1 publication Critical patent/AR069511A1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Abstract

Secuencias de nucleotidos que son variantes de secuencias de la recombinacion att, implicadas en a recombinacion de ADN con especificidad de secuencia en células eucariotas, donde la recombinacion con especificidad de secuencia se realiza por una integrasa Int del bacteriofago lambda. Estas secuencias de recombinacion son, por ejemplo, attP.b, attP.a, attL.a, attR.a y attR.b. Estas secuencia att permiten una integracion estable del sistema de recombinacion y el direccionamiento de una secuencia de ADN deseada. Se refiere además a un método de recombinacion de ADN con especificidad de secuencia en células eucariotas, que comprende introducir un primer ADN que comprende una secuencia de nucleotidos que contiene al menos una secuencia de recombinacion en una célula, introducir un segundo ADN que comprende una secuencia de nucleotidos que contiene al menos una secuencia de recombinacion adicional en una célula, y realizar la recombinacion con especificidad de secuencia por una integrasa Int del bacteriofago lambda, donde al menos uno de dichos primer o segundo ADN es una secuencia de recombinacion att que es, por ejemplo, attP.b, attP.a, attL.a, attR.a y attR.b. Asimismo se proveen vectores y células que los contienen. Reivindicacion 1: Una molécula de ácido nucleico caracterizada porque es seleccionada entre el grupo consistente attP.b (SEC ID N°:3), attP.a (SEC ID N°:4), attL.a (SEC ID N°:7), attR.a (SEC ID N°:10) y attR.b (SEC ID N°:11) o un derivado u homologo de la misma.
ARP080105224A 2007-11-30 2008-11-28 Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas Pending AR069511A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122004 2007-11-30
EP08157764 2008-06-06

Publications (1)

Publication Number Publication Date
AR069511A1 true AR069511A1 (es) 2010-01-27

Family

ID=40379677

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105224A Pending AR069511A1 (es) 2007-11-30 2008-11-28 Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas

Country Status (8)

Country Link
US (1) US8404486B2 (es)
EP (1) EP2217710A1 (es)
JP (1) JP2011504741A (es)
KR (1) KR101608225B1 (es)
AR (1) AR069511A1 (es)
CA (1) CA2706050C (es)
TW (1) TW200930815A (es)
WO (1) WO2009068645A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9234195B2 (en) 2010-11-25 2016-01-12 Applied Stemcell, Inc. Enhanced gene expression
US11078493B2 (en) * 2016-06-21 2021-08-03 Nanyang Technological University Site-specific DNA recombination
CN110997925A (zh) * 2017-08-11 2020-04-10 勃林格殷格翰国际有限公司 Cho细胞中的整合位点
WO2023201243A1 (en) * 2022-04-13 2023-10-19 Baylor College Of Medicine Bacterial biosensors for diagnosing and treating inflammation
CN117430696A (zh) * 2022-07-22 2024-01-23 北京智仁美博生物科技有限公司 用于表达Fab片段库的重组系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670823B1 (en) 1999-03-02 2010-03-02 Life Technologies Corp. Compositions for use in recombinational cloning of nucleic acids
WO1996040724A1 (en) 1995-06-07 1996-12-19 Life Technologies, Inc. Recombinational cloning using engineered recombination sites
DE19941186A1 (de) 1999-08-30 2001-03-01 Peter Droege Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen
WO2005017170A2 (en) 2002-06-04 2005-02-24 Michele Calos Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
TW200502390A (en) 2002-11-28 2005-01-16 Peter Droege Sequence specific DNA recombination in eukaryotic cells
JP2004248509A (ja) * 2002-11-29 2004-09-09 Boehringer Ingelheim Pharma Gmbh & Co Kg 真核細胞内における配列特異的ｄｎａ組換え

Also Published As

Publication number Publication date
CA2706050C (en) 2019-01-22
EP2217710A1 (en) 2010-08-18
US8404486B2 (en) 2013-03-26
CA2706050A1 (en) 2009-06-04
JP2011504741A (ja) 2011-02-17
WO2009068645A1 (en) 2009-06-04
US20110189729A1 (en) 2011-08-04
KR101608225B1 (ko) 2016-04-01
KR20100097123A (ko) 2010-09-02
TW200930815A (en) 2009-07-16

Similar Documents

Publication Publication Date Title
US11118224B2 (en) Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
US20230159996A1 (en) Multiplexed signal amplification
ES2962434T3 (es) Procedimientos y composiciones para editar ARN
Zimmerly et al. Evolution of group II introns
Pardue et al. Retrotransposons provide an evolutionarily robust non-telomerase mechanism to maintain telomeres
ES2764096T3 (es) Bibliotecas de secuenciación de próxima generación
FI3250691T3 (fi) Crispr hybridi dna/rna polynukleotidit ja käyttömenetelmät
CN111328343A (zh) Rna靶向方法和组合物
ES2687468T3 (es) Método de amplificación de ADN basado en invasión de cadena
AR069511A1 (es) Secuencias de recombinacion att que permiten la generacion de un sistema mejorado de expresion de proteinas
Osanai et al. Identification and characterization of the telomerase reverse transcriptase of Bombyx mori (silkworm) and Tribolium castaneum (flour beetle)
KR20220034109A (ko) 반합성 유기체의 복제, 전사 및 번역을 위한 시약 및 방법
WO2021041267A1 (en) Enzymatic rna capping method
BRPI0512791A (pt) sistema de transferência de gene biológico para células eucarióticas
JP2024010087A (ja) 非天然塩基対組成物および使用の方法
ES2383716T3 (es) Composiciones y métodos que utilizan ARN de interferencia de un gen del tipo OPR3 para el control de nemátodos
ES2506466T3 (es) Plásmido auto-supresor
BR112019017657A2 (pt) método para replicação ou amplificação de dna circular
TW202128994A (zh) 真核半合成生物
AR065282A1 (es) Composiciones y metodos que utilizan arn de transferencia de genes tipo cad para el control de nematodos
TW202128996A (zh) 用於活體內合成非天然多肽的組合物及方法
CL2020002973A1 (es) Casetes de expresión de a- glucosidasa de ácido optimizado con codón y métodos de uso del mismo
MX2021008867A (es) Composiciones reactantes marcadas de intensidad alta y metodos de secuenciamiento.
EA201070229A1 (ru) Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения
AU2020336278A1 (en) Enzymatic RNA capping method

Legal Events

Date Code Title Description
FB Suspension of granting procedure